.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Boehringer Ingelheim
AstraZeneca
Dow
Mallinckrodt
Cipla
Julphar
Chubb
Harvard Business School
Covington

Generated: November 18, 2017

DrugPatentWatch Database Preview

SOTRET Drug Profile

« Back to Dashboard

What is the patent landscape for Sotret, and when can generic versions of Sotret launch?

Sotret is a drug marketed by Sun Pharm Inds Ltd and is included in two NDAs.

The generic ingredient in SOTRET is isotretinoin. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.

Medical Subject Heading (MeSH) Categories for SOTRET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
SOTRET
isotretinoin
CAPSULE;ORAL076503-001Jun 20, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
SOTRET
isotretinoin
CAPSULE;ORAL076041-003Dec 24, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
SOTRET
isotretinoin
CAPSULE;ORAL076041-001Dec 24, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
SOTRET
isotretinoin
CAPSULE;ORAL076041-002Dec 24, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Teva
Colorcon
Moodys
Deloitte
Fuji
Express Scripts
US Department of Justice
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot